← All trials
NCT03563690
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 24, 2018
- Primary completion
- Dec 31, 2021
- Completion date
- Dec 31, 2022
- First posted
- —
- Last posted
- —
- Enrollment
- 360
- Arms / groups
- 6 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Zhejiang Chinese Medical UniversityLead sponsor
- Zhejiang Chinese Medical UniversityCollaborator
- Jiaxing TCM HospitalCollaborator
- Red Cross Hospital, Hangzhou, ChinaCollaborator
- Zhejiang UniversityCollaborator
- Zhejiang Chinese Medical UniversityReponsible party - principal investigator
- Zhejiang UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.